BBNX

Beta Bionics, Inc.

Healthcare · Medical Devices · —

22.80$ +3.5% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow BBNX
Line item	2022	2023	2024	2025
Operating Cash Flow	-1.40	-0.76	-1.13	-1.26
Depreciation & Amortization	0.05	0.05	0.05	0.07
Stock-Based Compensation	0.14	0.13	0.15	0.40
Change in Working Capital	-0.07	-0.12	-0.28	-0.22
Capital Expenditures	0.02	0.01	0.08	0.13
Investing Cash Flow	-0.02	-1.63	-0.08	-4.02
Financing Cash Flow	1.32	2.36	1.30	5.30
Change in Cash	-0.10	-0.03	0.09	0.03
Free Cash Flow	-1.42	-0.77	-1.21	-1.39

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.